title: Use of prophylactic antibiotics for prevention of intravascular catheter-related infections in interleukin-2-treated patients.
authors: Division of Cancer Treatment, National Cancer Institute, Frederick, MD 21701.
authors: L C
authors: LC
authors: Hartmann
authors: W J
authors: WJ
authors: Urba
authors: R G
authors: RG
authors: Steis
authors: J W
authors: JW
authors: Smith
authors: L A
authors: LA
authors: Vander Molen
authors: S P
authors: SP
authors: Creekmore
authors: M
authors: M
authors: Sznol
authors: M A
authors: MA
authors: Casciano
authors: N
authors: N
authors: Engler
authors: D L
authors: DL
authors: Longo
mesh_terms: D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002405:Catheterization, Central Venous / Q000009:adverse effects; D002408:Catheters, Indwelling / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000628:therapy*; D011446:Prospective Studies; D018805:Sepsis / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000900:Anti-Bacterial Agents; D007376:Interleukin-2